US 11389544
Formation of functionalized cancer targeting nanoparticles by supramolecular co-assembly
granted A61KA61K38/31A61K47/60
Quick answer
US patent 11389544 (Formation of functionalized cancer targeting nanoparticles by supramolecular co-assembly) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
- Grant date
- Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/31, A61K47/60, A61K47/64, A61K47/6929